Cargando…

Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.

Detalles Bibliográficos
Autores principales:	Csányi, E., Halász, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1967
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008114/ https://www.ncbi.nlm.nih.gov/pubmed/6028086

Ejemplares similares

Tumour-inhibiting Action of 1,6-Di-(2-Bromoethylamino)-1,6-Dideoxy-D-Mannitol Dihydrobromide [DBM (R13)]
por: Baló, J., et al.
Publicado: (1959)

Isolation of Genes Differentially Expressed between the Yoshida Sarcoma and Long‐survival Yoshida Sarcoma Variants: Origin of Yoshida Sarcoma Revisited
por: Tsuchiya, Haruo, et al.
Publicado: (1994)

The nature of the resistance to methylene dimethane sulphonate in the Yoshida sarcoma.
por: Fox, B. W., et al.
Publicado: (1973)

A Transferable “Resistance Factor” from in vitro Cultured MDMS-Resistant Yoshida Sarcoma Cells
por: Szende, B., et al.
Publicado: (1973)

Anti-Tumour Activity of the Fluorescent Dye, Acridine Orange, on Yoshida Sarcoma (Ascites)
por: Korgaonkar, K. S., et al.
Publicado: (1963)

Vaccination of Rats Against the Yoshida Ascites Sarcoma with the Formation of Complement-Fixing Antibody
por: Lund, Helge J. C.
Publicado: (1957)

DBM Threshold Scan
por: Schaefer, Douglas
Publicado: (2015)

First person – Nagisa Yoshida
Publicado: (2020)

The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.
por: Harrap, K. R., et al.
Publicado: (1969)

The Absorption, Distribution and Excretion of (3)H-Chlorambucil in Rats Bearing the Yoshida Ascites Sarcoma
por: Hill, Bridget T., et al.
Publicado: (1971)

Evaluation of bone healing in canine tibial defects filled with cortical autograft, commercial-DBM, calf fetal DBM, omentum and omentum-calf fetal DBM
por: Bigham-Sadegh, Amin, et al.
Publicado: (2013)

The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma.
por: Harrap, K. R., et al.
Publicado: (1969)

Influence of tumour volume and cell kinetics on the response of the solid Yoshida sarcoma to hyperthermia (42 degrees C).
por: Calderwood, S. K., et al.
Publicado: (1980)

Comparison of Oxygen Tensions in Normal Tissues and Yoshida Sarcoma of the Rat Breathing Air or Oxygen at 4 Atmospheres
por: Jamieson, Dana, et al.
Publicado: (1963)

Mode d'emploi du programme DBM
por: Mary, J-L
Publicado: (1992)

DBM-DB: the diamondback moth genome database
por: Tang, Weiqi, et al.
Publicado: (2014)

2,6-Dideoxy-2,6-imino-l-glycero-d-ido-heptitol
por: Jenkinson, Sarah F., et al.
Publicado: (2009)

Fluorine effect in nucleophilic fluorination at C4 of 1,6-anhydro-2,3-dideoxy-2,3-difluoro-β-D-hexopyranose
por: Lainé, Danny, et al.
Publicado: (2020)

6,8-Dibromoquinoline
por: Çelik, Ísmail, et al.
Publicado: (2010)

3,6-Dibromophenanthrene
por: Yokota, Ruri, et al.
Publicado: (2012)

Optimization of Bacterial Plasmid Transformation Using Nanomaterials Based on the Yoshida Effect
por: Tan, Haidong, et al.
Publicado: (2010)

Initial Validation of the Diabetes and Breastfeeding Management Questionnaire (DBM-Q)
por: Linden, Karolina, et al.
Publicado: (2020)

Demineralized Bone Matrix (DBM) as a Bone Void Filler in Lumbar Interbody Fusion: A Prospective Pilot Study of Simultaneous DBM and Autologous Bone Grafts
por: Kim, Bum-Joon, et al.
Publicado: (2017)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
por: Guo, Dongwei, et al.
Publicado: (2017)

1-Deoxy-l-mannitol (6-deoxy-l-mannitol or l-rhamnitol)
por: Jenkinson, Sarah F., et al.
Publicado: (2008)

Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).
por: Dessí, S., et al.
Publicado: (1992)

N-Benzyl-1,3-dideoxy-1,3-imino-l-xylitol
por: Jenkinson, Sarah F., et al.
Publicado: (2011)

A Survey of Recent Synthetic Applications of 2,3-Dideoxy-Hex-2-enopyranosides
por: Gomez, Ana M., et al.
Publicado: (2015)

2,6-Dibromo-4-chloroaniline
por: Ali, Umar Sharif, et al.
Publicado: (2012)

2,6-Dibromo-4-butylaniline
por: Zhao, Liang, et al.
Publicado: (2010)

4,6-Dibromoisophthalic acid monohydrate
por: Ye, Bao-fen
Publicado: (2012)

2′,10′-Dibromospiro[cylohexane-1,6-dibenzo[d,f][1,3]dioxepine]
por: Zhang, Cheng-Bo, et al.
Publicado: (2010)

Elastic intramedullary nailing and DBM-Bone marrow injection for the treatment of simple bone cysts
por: Kanellopoulos, Anastasios D, et al.
Publicado: (2007)

Is DBM Beneficial for the Enhancement of Bony Consolidation in Distraction Osteogenesis? A Randomized Controlled Trial
por: Song, Sang-Heon, et al.
Publicado: (2015)

Coculture of allogenic DBM and BMSCs in the knee joint cavity of rabbits for cartilage tissue engineering
por: Xu, Bin, et al.
Publicado: (2017)

Double Burden of Malnutrition (DBM) and Anaemia under the Same Roof: A Bangladesh Perspective
por: Mamun, Sumaiya, et al.
Publicado: (2019)

Construction of three-dimensional, homogeneous regenerative cartilage tissue based on the ECG-DBM complex
por: Liu, Jingwen, et al.
Publicado: (2023)

Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4- and -2-keto-β-d-glucopyranosyl derivatives of N(4)-benzoyl cytosine
por: Manta, Stella, et al.
Publicado: (2009)

Ethyl 5,8-dibromo-2-dibromomethyl-6,7-dimethoxyquinoline-3-carboxylate
por: Zhou, Ting, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kde3dqfong2q4fub1hmdcgqeep